Rheumatoid arthritis (Q44270): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A artrite reumatoide (AR) é uma doença persistente e/ou erosiva, definida como a presença confirmada de sinovite em pelo menos 1 articulação, ausência de um diagnóstico alternativo que melhor explique a sinovite e obtenção de uma pontuação de 6 ou mais (de uma pontuação total de 10) nas pontuações individuais em 4 domínios: número e local das articulações envolvidas, alterações sorológicas, provas de atividade inflamatória elevadas e duração dos sintomas.
description / endescription / en
 
Rheumatoid arthritis (RA) is persistent and/or erosive disease that is defined as the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints, serologic abnormality, elevated acute-phase response, and symptom duration.

Revision as of 11:40, 13 August 2026

Rheumatoid arthritis (RA) is persistent and/or erosive disease that is defined as the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints, serologic abnormality, elevated acute-phase response, and symptom duration.
Language Label Description Also known as
default for all languages
FA20
    English
    Rheumatoid arthritis
    Rheumatoid arthritis (RA) is persistent and/or erosive disease that is defined as the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints, serologic abnormality, elevated acute-phase response, and symptom duration.

      Statements